Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from Twitter…
Online publication should make publishing faster, but it still takes months to get a paper published. In competitive fields, it’s not unlikely that the credit for the first published paper on a new discovery doesn’t necessarily go to the researcher who was the first to complete the work, but to the one who happened to…
“Does anyone know any life scientists or clinicians in Antarctica interested in publishing innovation?” we found ourselves wondering last week. It’s the only continent on which we have not appointed an F1000 Specialist – yet (although given the overwhelming response so far, we remain optimistic). In July we received more than 60 applications to join…
Everyone likes a good science joke, so on Friday, we asked our Twitter followers what their favourites were…
Releasing information in incremental steps is nothing new to software developers, who release updates and patches that add new functionality to existing programmes. The launch of a new bioinformatics tool is often accompanied by a paper describing the tool for new users. However, the paper describing the tool will be out of date as soon…
A round-up of the most popular Tweets from @F1000, as well as a taste of some of the science jokes we’ve been giggling at all day…
A year ago today, F1000Research launched its preliminary site. Among the very first papers published on that day was Manuel Corpas’ paper “Low budget analysis of Direct-To-Consumer genomic testing familial data”, in which he evaluated the potential of public domain analysis tools for personal genomics. Now, a year later, we followed up with Manuel to…
Christer Allgulander is a senior lecturer in psychiatry at the Karolinska Institutet, Stockholm and a member of the Anxiety Disorders section of the Psychiatry Faculty of F1000Prime. Last week, Professor Allgulander visited our office in London, and was kind enough to spend some time talking to us about his current research. In this video, Professor…
Ethan Perlstein left academia to become an independent researcher, investigating rare diseases. In this guest post, he explains how he arrived at this decision, and what his plans are. Recently I declared scientific independence and a newfound focus on rare/orphan diseases…on my blog. This decision was not planned far in advance. It’s more adaptation to…
Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from the rest of Twitter…
